Skip to main content
Article
NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematologic Malignancies
Biology of Blood and Marrow Transplantation (2010)
  • Edwin P. Alyea, Harvard University
  • Daniel J. DeAngelo, Harvard University
  • Jeffrey Moldrem, University of Texas MD Anderson Cancer Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Donna Przepiorka, Food and Drug Administration
  • Michel Sadelin, Memorial Sloan Kettering Cancer Center
  • James W. Young, Memorial Sloan Kettering Cancer Center
  • Sergio Giralt, University of Texas MD Anderson Cancer Center
  • Michael Bishop, National Institutes of Health
  • Stan Riddell, Fred Hutchinson Cancer Research Center
Publication Date
January 8, 2010
DOI
10.1016/j.bbmt.2010.05.005
Citation Information
Edwin P. Alyea, Daniel J. DeAngelo, Jeffrey Moldrem, John M. Pagel, et al.. "NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematologic Malignancies" Biology of Blood and Marrow Transplantation Vol. 16 Iss. 8 (2010) p. 1037 - 1069
Available at: http://works.bepress.com/john-pagel/205/